Nicolò Pettenuzzo

Nicolò Pettenuzzo

Auto-generated profile, based on publicly available information

Nicolò Pettenuzzo

“Claudio Buonerba” Research Center, Plant of Mantova, Versalis (Eni) S.p.A., Via Taliercio 14, 46100 Mantova, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2016 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
CNChiara Nardon
Chiara Nardon
NPNicolò Pettenuzzo
Nicolò Pettenuzzo
DFDolores Fregona
Dolores Fregona
Gold has always aroused great interest in the history of mankind. It has been used for thousands of years for jewelry, religious cult valuables, durable goods and in the art world. However, few know that such a precious and noble metal was exploited in the past by the ancients also for its therapeutic properties. More recently, in the twentieth century some complexes containing gold centers in the oxidation state +1 were studied for the treatment of the rheumatoid arthritis and the orally-administered drug Auranofin was approved by the FDA in 1985. From the chemical point of view, gold derivatives deserve special attention due to the unique position of this metal within the periodic table, which results in unconventional relativistic effects and, ultimately, in the highest electronegativity, electron affinity and redox potential among all metals. In this review, after an introduction concerning the use of gold complexes in medicine, we have examined all the patents internationally or nationally published in the years 2010-2015 (until December 31, 2015) and describing new inorganic compounds containing gold(I) and gold(III) with proved therapeutic properties. These patents were filed to mainly protect compounds with promising anticancer and anti-inflammatory activities (total 18 and 4, respectively). In particular, this work explores both coordination compounds containing ligands with various donor atoms (e.g., N-, O-, S- and -P) and organo-gold derivatives with at least one Au-C bond. The toxicological profile and the intracellular targets reported for some among the patented gold derivatives are discussed.

4 October 2018 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
LBL. Brustolin
L. Brustolin
CNC. Nardon
C. Nardon
NPN. Pettenuzzo
N. Pettenuzzo
NFN. Zuin Fantoni
N. Zuin Fantoni
SQS. Quarta
S. Quarta
DFDolores Fregona
Dolores Fregona
In this paper, we focused on the analysis of the effects mediated by different cyclic dithiocarbamic ligands (DTC) on three classes of antiproliferative coordination compounds, namely, Ru(III) complexes with the general formulae [Ru(DTC)3] and [Ru2(DTC)5]Cl, and the neutral Cu(II) derivatives of the type [Cu(DTC)2]. In particular, we present the synthesis and characterization of a library of total 23 coordination compounds containing Ru(III) or Cu(II) as the biologically-active metal center and two or more dithiocarbamato (DTC) ligands derived from cyclic amines (aliphatic or aromatic). Several techniques including elemental analysis, X-ray crystallography, ESI-MS, 1H-NMR spectroscopy, FT-IR and UV-Vis spectrophotometry were used to characterize the compounds, which highlighted the different electronic behaviors generated by the substituents within the DTC moiety. Moreover, the synthesized compounds were tested for their stability in order to investigate their antiproliferative activity against 3 human cancer cell lines, namely, HeLa, HepG2 and HepG2/SB3. In particular, HepG2/SB3 was chosen for its aggressiveness due to upregulation of the anti-apoptotic protein SerpinB3. Finally, the most promising compounds are studied in terms of log P. Overall, the results reveal the drug-likeness of some of the derivatives of copper(II) and ruthenium(III).

1 September 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Marianna Flora TomaselloMarianna Flora Tomasello
Marianna Flora Tomasello
CNChiara Nardon
Chiara Nardon
VLValeria Lanza
Valeria Lanza
GNGiuseppe Di Natale
Giuseppe Di Natale
NPNicolò Pettenuzzo
Nicolò Pettenuzzo
DFDolores Fregona
Dolores Fregona

10 November 2016 in European Journal of Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
CNChiara Nardon
Chiara Nardon
GBGiulia Boscutti
Giulia Boscutti
Chiara GabbianiChiara Gabbiani
Chiara Gabbiani
LMLara Massai
Lara Massai
NPNicolò Pettenuzzo
Nicolò Pettenuzzo
DFDolores Fregona
Dolores Fregona
AuL10 ([AuIIICl2(dmdt)], dmdt = N,N‐dimethyldithiocarbamate) and AuL12 ([AuIIIBr2(esdt)], esdt = ethylsarcosine dithiocarbamate) are two extremely promising gold‐based anticancer compounds. Their mechanisms of action are still largely unknown although some specific hypotheses have been proposed. To shed light on their reactivity with probable biological targets, we report here on their interactions with serum albumin and calf‐thymus DNA, taken as model biomolecules. Quite unexpectedly, spectrophotometric investigations revealed substantially different patterns of interaction for these two gold complexes with the aforementioned biomolecules, probably arising from differences in redox chemistry. Afterwards, AuL12 was tested against A549 human non‐small‐cell lung carcinoma cells, evaluating its real‐time profile of cell‐growth inhibition by means of the xCELLigence Real‐Time Cell Analysis system. Measures of impedance by non‐invasive gold microelectrodes at the base of each well indicated that this gold complex inhibits cell proliferation after only 4 h of treatment, producing its cytotoxic effects probably at the membrane level.

15 May 2019 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
NPNicolò Pettenuzzo
Nicolò Pettenuzzo
LBLeonardo Brustolin
Leonardo Brustolin
ECElisa Coltri
Elisa Coltri
AGAlberto Gambalunga
Alberto Gambalunga
FCFederica Chiara
Federica Chiara
DFDolores Fregona
Dolores Fregona

1 December 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
LBLeonardo Brustolin
Leonardo Brustolin
NPNicolò Pettenuzzo
Nicolò Pettenuzzo
CNChiara Nardon
Chiara Nardon
SQSantina Quarta
Santina Quarta
IMIsabella Montagner
Isabella Montagner
DFDolores Fregona
Dolores Fregona